Corporate-Backed Blue Dogs Threaten Democrats’ Budget Plan
Facing health care and climate crises, a group of six conservative House Democrats are seeking to pump the brakes on the largest federal investments in decades.
Page 8
Facing health care and climate crises, a group of six conservative House Democrats are seeking to pump the brakes on the largest federal investments in decades.
Researchers studying congressional stock ownership have found that the practice has effects on lobbying activity and potentially on market movements.
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
So far this year, Paul Pelosi has purchased stock in companies including Tesla, Walt Disney, Apple, Facebook, and Amazon.
ExxonMobil’s most recent worldwide giving report, covering 2019, shows it funds multiple climate denial groups.
Last week, the House Judiciary Committee approved a sweeping package of antitrust bills, one overcoming opposition from Democrats hailing from tech industry-heavy California.
Its founders are among the top fundraisers from corporate PACs in the House Democratic caucus.
On average, the signers received $93,275 from the pharmaceutical & health products industry in the 2020 cycle, far more than the average for House Democrats of $37,788.
Americans for Prosperity is hitting six key moderate House Democrats with digital ads opposing reintroduced drug pricing measures.
The automaker took just three weeks to assess the Jan. 6 riots before restarting PAC donations to Republican election objectors.